United Therapeutics Corporation Presents New Data Spanning Pulmonary Hypertension Treatment, Lung Donor Expansion, and Xenotransplantation at ISHLT 2026
Go back to United Therapeutics Corporation Presents New Data Spanning Pulmonary Hypertension Treatment, Lung Donor Expansion, and Xenotransplantation at ISHLT 2026| United Therapeutics Corp (NASDAQ: UTHR) | Delayed: 538.30 +1.71 (0.32%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $536.59 | 52 Week High | $164.04 | |||
| Open | $541.25 | 52 Week Low | $97.52 | |||
| Day High | $541.53 | P/E | 98.41 | |||
| Day Low | $533.49 | EPS | $5.47 | |||
| Volume | 614,960 | |||||
